Pharmafile Logo
Pharmafocus logo
Advanced Search

Shares

Showing 8 posts of 23 posts found.

stocks1

Weekly Movers: Global Blood Therapeutics, Sophiris Bio…

June 20, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …

Feature
stocks1

Weekly Movers: Lion Biotech, Adamis, Sarepta…

June 13, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Alexion, Biogen, Shares, Stock Markets, Stock Movement, drug trial, sarepta

Drug trial results remained the important theme over the past week with several companies announcing key study results. The trial …

Feature
stocks3

Losses and profit forecast cuts send shares tumbling again at Valeant

June 8, 2016
Research and Development, Sales and Marketing Shares, Valeant, cut, forecast, tumbling

Valeant Pharmaceuticals has published its results for the first quarter, which has seen the firm post a net loss of …

News
figures_charts

Shares plunge at Sarepta after negative FDA review on muscle disorder drug

April 21, 2016
Research and Development, Sales and Marketing FDA, Sarepta Therapeutics, Shares, dive, fall, negative, plunge, sarepta

Sarepta Therapeutics (NASDAQ: SPRT) is counting the cost as shares plunge following a negative review given by staff at the …

News

Illumina shares plunge as it cuts Q1 outlook

April 20, 2016
Research and Development, Sales and Marketing Financial, Illumina, Share price, Shares, outlook, revenue, stock market

Shares in Illumina (Nasdaq: ILMN) plunged after the company cut its revenue estimates for the first quarter based on low …

News
hospital

Repros Therapeutics says positive results from Phase II trial of uterine fibroids drug; shares jump

April 15, 2016
Medical Communications, Research and Development Repros Therapeutics, Shares, US FDA, drug trial, uterine fibroids

Shares in Repros Therapeutics (Nasdaq: RPRX) surged to close over 18% Thursday after the company announced positive mid-stage trial results …

News
7-0_careers_taleobanner_900x600

Baxter to cut stake in Baxalta

March 17, 2016
Business Services, Sales and Marketing Baxalta, Shares, Stake sale, baxter

Baxalta Inc (NYSE: BXLT) said former parent company Baxter International (NYSE: BAX) is set to cut its stake in the …

News

Pfizer’s India unit stops production of cough drug, shares drop almost 8%

March 14, 2016
Business Services, Sales and Marketing Bombay Stock Exchange, Corex, Pfizer Inc, Pfizer Ltd, Shares

Shares in the Indian arm of drug major Pfizer Inc (NYSE: PFE) dropped nearly 8% on the Bombay Stock Exchange …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026